Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course (Q37209876)
Jump to navigation
Jump to search
scientific article published on October 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course |
scientific article published on October 2008 |
Statements
1 reference
Drug-susceptible HIV-1 infection despite intermittent fixed-dose combination tenofovir/emtricitabine as prophylaxis is associated with low-level viremia, delayed seroconversion, and an attenuated clinical course (English)
1 reference
Mary Carrington
1 reference
Nicole Prada
1 reference
Brandi Davis
1 reference
Patrick Jean-Pierre
1 reference
Matthew La Roche
1 reference
Fuh-Mei Duh
1 reference
Michael Poles
1 reference
Saurabh Mehandru
1 reference
Hiroshi Mohri
1 reference
Martin Markowitz
1 reference
1 reference
1 reference
Identifiers
1 reference